TABLE 2.
Ellipticity, tryptophan fluorescence emission shift, and activities of MesY105 and its derivativesa
Peptide | % by CDb
|
Fluorescence emission shift (Δλmaxc [nm]) | Biological activity (MICd [nM]) | |||
---|---|---|---|---|---|---|
Aqueous buffer
|
C13-LPC micelles (Ri = 40)
|
|||||
Unstructured | Hα | Unstructured | Hα | |||
MesY105 | 68 | 7 | 26 | 24 | 9 | 1.6 |
H8Y | 50 | 10 | 59 | 17 | 11 | 31 |
H8L | 64 | 9 | 31 | 22 | 10 | 83 |
G13E | 45 | 13 | 46 | 19 | 6 | 130 |
S15F | 58 | 8 | 37 | 23 | 10 | 4.1 |
W18F | 76 | 5 | 27 | 24 | 9 | 21 |
A21V | 61 | 6 | 37 | 24 | 13 | 73 |
A24P | 58 | 9 | 60 | 15 | 4 | 9,700 |
R28H | 66 | 8 | 73 | 9 | 1 | 20,000 |
W37F | 77 | 4 | 37 | 21 | 14 | 47 |
Mes36 | 76 | 6 | 52 | 14 | 6 | 27,000 |
Standard deviations are less than 5%.
Percentage of amino acid residues in unstructured or α-helix state.
Change in the maximum fluorescence emission wavelength observed upon addition of LPC micelles.
MIC data were obtained with at least three independent activity assays against L. ivanovii Li4(pVS2) (2).